SCHEMBL13533

SCHEMBL13533

Bc1ccc2c(cnn2CCC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.43
HTR2C P28335 6/20 0.43
KMO O15229 3/20 0.42
GLS O94925 1/20 0.41
CACNA1H O95180 2/20 0.39
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.36
RECQL P46063 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR2B P41595 3/20 0.36
MAOB P27338 2/20 0.35
MAOA P21397 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
HTR1A P08908 2/20 0.34
ADRA2A P08913 2/20 0.34
ADRA2B P18089 2/20 0.34
ADRA2C P18825 2/20 0.34
HTR1D P28221 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12680052 0.81 KMO (0.50) HTR2AHTR2CKMOGLSCACNA1H
SCHEMBL13548 0.80 KMO (0.49) HTR2AHTR2CKMOGLSCACNA1H
SCHEMBL29200969 0.80 CHEK1 (0.50) HTR2AHTR2CKMOGLSCACNA1H
SCHEMBL15341861 0.78 HTR2A (0.44) HTR2AHTR2CKMOGLSCACNA1H
SCHEMBL13592 0.77 TRPA1 (0.45) CYP1A2MAOBMAOAPDE1C
SCHEMBL23497966 0.76 CYP2A6 (0.47) HTR2AHTR2CKMOGLSCACNA1H
SCHEMBL30044048 0.76 CYP2A6 (0.47) HTR2AHTR2CKMOGLSCACNA1H
SCHEMBL29487638 0.75 CYP1A2 (0.62) KMOCYP1A2POLBRECQLHSD17B10
SCHEMBL5565705 0.75 CYP1A2 (0.62) KMOCYP1A2POLBRECQLHSD17B10
SCHEMBL11888551 0.74 MCHR1 (0.40) HTR2AHTR2CKMOGLSCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011044187-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE SCHERING CORPORATION (US) 2011-04-14 WO disclosed